For brands selling products into retail stores, this shift reshapes opportunity—and for those who understand it, it creates a ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

With improved model capabilities, Anthropic Opus 4.6 is an example, the same wave is now hitting science itself. If code is no longer the bottleneck—if generating, testing, and iterating on ...

Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.

The first is valuation discipline. AI startups often command premium valuations driven by technological promise rather than ...

China’s annual Two Sessions gathering has long served as a showcase for growth priorities, industrial strategy and technological ambition. This year, however, one theme is becom ...

How Are Non-Human Identities Redefining Cybersecurity? What are the implications of Non-Human Identities (NHIs) on contemporary cybersecurity strategies? Where increasingly reliant on digital, NHIs ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

Find the best actuarial exam prep courses. Expert reviews of top platforms, including lifetime access, adaptive learning, and free options.

Geography once drove disparity, but access now hinges on how effectively centers can employ modern donor-utilization tools.

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...